MRI assessment of iron deposition in multiple sclerosis

Journal of Magnetic Resonance Imaging

Volumn 34, Issue 1, 2011, Pages 13-21

  Ropele, Stefan ^a   De Graaf, Wolter ^b   Khalil, Michael ^a   Wattjes, Mike P ^b   Langkammer, Christian ^a   Rocca, Maria A ^c   Rovira, Alex ^d   Palace, Jacqueline ^e   Barkhof, Frederik ^b   Filippi, Massimo ^c   Fazekas, Franz ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

iron; magnetic field correlation imaging; magnetic susceptibility; MRI; multiple sclerosis; relaxation time mapping

Indexed keywords

FERRITIN; IRON; LIPID; PROTON; WATER;

AMYGDALOID NUCLEUS; ARTIFACT; BASAL GANGLION; BRAIN CORTEX; BRAIN LEVEL; BRAIN MAPPING; BRAIN REGION; BRAIN STEM; CAUDATE NUCLEUS; COLORIMETRY; DIRECT SATURATION IMAGING; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; GLOBUS PALLIDUS; GRAY MATTER; HIPPOCAMPUS; HUMAN; IRON STORAGE; LOCAL FIELD SHIFT; MAGNETIC FIELD CORRELATION IMAGING; MASS SPECTROMETRY; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PHASE IMAGING; PRIORITY JOURNAL; PUTAMEN; QUANTITATIVE ANALYSIS; QUANTITATIVE SUSCEPTIBILITY MAPPING; RADIOFREQUENCY RADIATION; RADIOLOGICAL PARAMETERS; RELAXATION TIME MAPPING; REVIEW; SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SENSORIMOTOR CORTEX; SIGNAL NOISE RATIO; SUSCEPTIBILITY WEIGHTED IMAGING; THALAMUS; TISSUE LEVEL; X RAY FLUORESCENCE;

BRAIN; FOURIER ANALYSIS; HUMANS; IRON; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MAGNETICS; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; TIME FACTORS;

EID: 79959604087     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22590     Document Type: Review

References (61)

1. Andrews NC,. Disorders of iron metabolism. N Engl J Med 1999; 341: 1986-1995. (Pubitemid 30010408)
2. Altamura S, Muckenthaler MU,. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. J Alzheimers Dis 2009; 16: 879-895.
3. Orino K, Lehman L, Tsuji Y, Ayaki H, Torti SV, Torti FM,. Ferritin and the response to oxidative stress. Biochem J 2001; 357: 241-247. (Pubitemid 32642922)
4. Bothwell TH,. Overview and mechanisms of iron regulation. Nutr Rev 1995; 53: 237-245.
5. Hallgren B, Sourander P,. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958; 3: 41-51.
6. Schenck JF, Zimmerman EA,. High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed 2004; 17: 433-445. (Pubitemid 39549421)
7. Stankiewicz J, Panter SS, Neema M, Arora A, Batt CE, Bakshi R,. Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics 2007; 4: 371-386. (Pubitemid 46962416)
8. Craelius W, Migdal MW, Luessenhop CP, Sugar A, Mihalakis I,. Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 1982; 106: 397-399.
9. LeVine SM,. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res 1997; 760: 298-303. (Pubitemid 27304170)
10. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H,. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000; 47: 707-717. (Pubitemid 30390191)
11. Lassmann H, Bruck W, Lucchinetti CF,. The immunopathology of multiple sclerosis: an overview. Brain Pathol 2007; 17: 210-218. (Pubitemid 46466140)
12. Singh AV, Zamboni P,. Anomalous venous blood flow and iron deposition in multiple sclerosis. J Cereb Blood Flow Metab 2009; 29: 1867-1878.
13. Zivadinov R, Schirda C, Dwyer MG, et al. Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study. Int Angiol 2010; 29: 158-175.
14. Vymazal J, Brooks RA, Baumgarner C, et al. The relation between brain iron and NMR relaxation times: an in vitro study. Magn Reson Med 1996; 35: 56-61. (Pubitemid 26017919)
15. Vymazal J, Brooks RA, Zak O, McRill C, Shen C, Di Chiro G,. T1 and T2 of ferritin at different field strengths: effect on MRI. Magn Reson Med 1992; 27: 368-374.
16. Mitsumori F, Watanabe H, Takaya N,. Estimation of brain iron concentration in vivo using a linear relationship between regional iron and apparent transverse relaxation rate of the tissue water at 4.7T. Magn Reson Med 2009; 62: 1326-1330.
17. Langkammer C, Krebs N, Goessler W, et al. Quantitative MR imaging of brain iron: a postmortem validation study. Radiology 2010; 257: 455-462.
18. Drayer B, Burger P, Hurwitz B, Dawson D, Cain J,. Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? AJR Am J Roentgenol 1987; 149: 357-363. (Pubitemid 17104997)
19. Vymazal J, Brooks RA, Patronas N, Hajek M, Bulte JW, Di Chiro G,. Magnetic resonance imaging of brain iron in health and disease. J Neurol Sci 1995; 134 (Suppl): 19-26.
20. Bakshi R, Shaikh ZA, Janardhan V,. MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport 2000; 11: 15-21. (Pubitemid 30053382)
21. Bakshi R, Benedict RH, Bermel RA, et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002; 59: 62-68. (Pubitemid 34052557)
22. Burgetova A, Seidl Z, Krasensky J, Horakova D, Vaneckova M,. Multiple sclerosis and the accumulation of iron in the basal ganglia: quantitative assessment of brain iron using MRI t(2) relaxometry. Eur Neurol 2010; 63: 136-143.
23. Vymazal J, Righini A, Brooks RA, et al. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology 1999; 211: 489-495. (Pubitemid 29206821)
24. Koenig SH, Kellar KE,. Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles. Magn Reson Med 1995; 34: 227-233.
25. Ogg RJ, Steen RG,. Age-related changes in brain T1 are correlated with iron concentration. Magn Reson Med 1998; 40: 749-753. (Pubitemid 28493654)
26. Gelman N, Ewing JR, Gorell JM, Spickler EM, Solomon EG,. Interregional variation of longitudinal relaxation rates in human brain at 3.0 T: relation to estimated iron and water contents. Magn Reson Med 2001; 45: 71-79. (Pubitemid 32044267)
27. Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005; 23: 1-25. (Pubitemid 40269946)
28. Ma J, Wehrli FW,. Method for image-based measurement of the reversible and irreversible contribution to the transverse-relaxation rate. J Magn Reson B 1996; 111: 61-69. (Pubitemid 126758658)
29. Gelman N, Gorell JM, Barker PB, et al. MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 1999; 210: 759-767. (Pubitemid 29124039)
30. Yablonskiy DA, Haacke EM,. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 1994; 32: 749-763. (Pubitemid 24371176)
31. Jensen JH, Chandra R,. NMR relaxation in tissues with weak magnetic inhomogeneities. Magn Reson Med 2000; 44: 144-156. (Pubitemid 30439850)
32. Yao B, Li TQ, Gelderen P, Shmueli K, de Zwart JA, Duyn JH,. Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. Neuroimage 2009; 44: 1259-1266.
33. Hopp K, Popescu BF, McCrea RP, et al. Brain iron detected by SWI high pass filtered phase calibrated with synchrotron X-ray fluorescence. J Magn Reson Imaging 2010; 31: 1346-1354.
34. Cusack R, Papadakis N,. New robust 3-D phase unwrapping algorithms: application to magnetic field mapping and undistorting echoplanar images. Neuroimage 2002; 16: 754-764. (Pubitemid 34852438)
35. Rauscher A, Barth M, Reichenbach JR, Stollberger R, Moser E,. Automated unwrapping of MR phase images applied to BOLD MR-venography at 3 Tesla. J Magn Reson Imaging 2003; 18: 175-180. (Pubitemid 36935948)
36. Hammond KE, Metcalf M, Carvajal L, et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol 2008; 64: 707-713.
37. Rauscher A, Sedlacik J, Barth M, Mentzel HJ, Reichenbach JR,. Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol 2005; 26: 736-742. (Pubitemid 43079761)
38. Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng YC,. Susceptibility- weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 2009; 30: 19-30.
39. Mittal S, Wu Z, Neelavalli J, Haacke EM,. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol 2009; 30: 232-252.
40. Haacke EM, Makki M, Ge Y, et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging 2009; 29: 537-544.
41. Schafer A, Wharton S, Gowland P, Bowtell R,. Using magnetic field simulation to study susceptibility-related phase contrast in gradient echo MRI. Neuroimage 2009; 48: 126-137.
42. Lee J, Shmueli K, Fukunaga M, et al. Sensitivity of MRI resonance frequency to the orientation of brain tissue microstructure. Proc Natl Acad Sci U S A 2010; 107: 5130-5135.
43. Marques JP, Bowtell R,. Application of a Fourier-based method for rapid calculation of field inhomogeneity due to spatial variation of magnetic susceptibility. Concepts Magn Reson Part B 2005; 25: 65.
44. Schweser F, Deistung A, Lehr BW, Reichenbach JR,. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: An approach to in vivo brain iron metabolism? Neuroimage 2010; 54: 2789-2807.
45. Jensen JH, Szulc K, Hu C, et al. Magnetic field correlation as a measure of iron-generated magnetic field inhomogeneities in the brain. Magn Reson Med 2009; 61: 481-485.
46. Jensen JH, Chandra R, Ramani A, et al. Magnetic field correlation imaging. Magn Reson Med 2006; 55: 1350-1361. (Pubitemid 43856773)
47. Smith SA, Bulte JW, van Zijl PC,. Direct saturation MRI: theory and application to imaging brain iron. Magn Reson Med 2009; 62: 384-393.
48. Hocq A, Brouette N, Saussez S, Luhmer M, Gillis P, Gossuin Y,. Variable-field relaxometry of iron-containing human tissues: a preliminary study. Contrast Media Mol Imaging 2009; 4: 157-164.
49. Drayer BP, Burger P, Hurwitz B, et al. Magnetic resonance imaging in multiple sclerosis: decreased signal in thalamus and putamen. Ann Neurol 1987; 22: 546-550. (Pubitemid 17164782)
50. Bermel RA, Puli SR, Rudick RA, et al. Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch Neurol 2005; 62: 1371-1376. (Pubitemid 41352053)
51. Tjoa CW, Benedict RH, Weinstock-Guttman B, Fabiano AJ, Bakshi R,. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis. J Neurol Sci 2005; 234: 17-24. (Pubitemid 40910338)
52. Zhang Y, Zabad RK, Wei X, Metz LM, Hill MD, Mitchell JR,. Deep grey matter "black T2" on 3 Tesla magnetic resonance imaging correlates with disability in multiple sclerosis. Mult Scler 2007; 13: 880-883. (Pubitemid 351540859)
53. Brass SD, Benedict RH, Weinstock-Guttman B, Munschauer F, Bakshi R,. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler 2006; 12: 437-444. (Pubitemid 44132584)
54. Neema M, Arora A, Healy BC, et al. Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis. J Neuroimaging 2009; 19: 3-8.
55. Ceccarelli A, Rocca MA, Neema M, et al. Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis. Mult Scler 2010; 16: 39-44.
56. Ceccarelli A, Filippi M, Neema M, et al. T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis. Mult Scler 2009; 15: 678-686.
57. Ge Y, Jensen JH, Lu H, et al. Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 2007; 28: 1639-1644. (Pubitemid 47598131)
58. Hammond KE, Lupo JM, Xu D, et al. Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. Neuroimage 2008; 39: 1682-1692.
59. Khalil M, Enzinger C, Langkammer C, et al. Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis. Mult Scler 2009; 15: 1048-1054.
60. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004; 23 (Suppl 1): S208-219. (Pubitemid 39421720)
61. Wattjes MP, Barkhof F,. High field MRI in the diagnosis of multiple sclerosis: high field-high yield? Neuroradiology 2009; 51: 279-292.